Chairman
Hans Schambye joined ReceptIcon in 2006 as Chief Executive Officer. Read more.

Board member
Christian Hansen is co-founder and partner of Nordic Biotech. Dr. Hansen has a strong background as a biotechnology entrepreneur, biotech intellectual property rights expert and business development executive, combined with a scientific career.
From 2000 to 2001 Dr. Hansen was co-President of Maxygen's Protein Pharma Division, and co-Managing Director of its Danish subsidiary Maxygen ApS, employing about 75 people. From 1999 to 2000, Dr. Hansen was co-CEO and founder of ProFound Pharma A/S, a Danish start-up company focused on developing 2nd generation protein pharmaceuticals. The company was sold to Maxygen, Inc. one year after inception for stock worth about USD 75 mill.
From 1992 to 1999, Dr. Hansen worked in various executive positions at Novo Nordisk A/S, including as Director of Intellectual Property Strategy, which is one of his core areas of expertise. In this capacity, Dr. Hansen was responsible for numerous patent, license and collaborative agreement strategies and negotiations, and was a member of Enzyme Research Management Group, which in turn was responsible for a 400 person international R&D organisation. Dr. Hansen was also a member of several cross-functional market-specific strategy groups at Novo Nordisk A/S.
Dr. Hansen holds an MSc (1989) in chemical engineering from the Technical University of Denmark and a PhD (1992) in molecular biology/biochemistry undertaken at the Institut Pasteur, Paris, and the University of Salamanca, Spain, as well as an MBA from the Edinburgh Business School. Dr. Hansen is listed as inventor in connection with more than 10 patent applications.

Board member
Florian Schönharting is co-founder and partner of Nordic Biotech. Read more.

Board member
Dr. Goesch is a director of BioScience Managers Limited (BML) which he joined in July 2002. Read more.

Board member
Wyle Solomon is Vice President at Nordic Biotech. He came to Nordic Biotech in June 2007. Read more.
